A rare cutaneous manifestation of immune checkpoint inhibitor therapy

Leukocytoclastic vasculitis can be an uncommon and/or underreported adverse event of immune checkpoint inhibitor therapy, an established cancer treatment option. Differentiation among other cutaneous manifestations of adverse medication reactions—such as Stevens–Johnson syndrome, erythema multiforme...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherneskie, John, Tuan, Alyssa, Corey, Zachary, Polimera, Hyma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067804/
https://www.ncbi.nlm.nih.gov/pubmed/37020667
http://dx.doi.org/10.1002/ccr3.7151
_version_ 1785018552218025984
author Cherneskie, John
Tuan, Alyssa
Corey, Zachary
Polimera, Hyma
author_facet Cherneskie, John
Tuan, Alyssa
Corey, Zachary
Polimera, Hyma
author_sort Cherneskie, John
collection PubMed
description Leukocytoclastic vasculitis can be an uncommon and/or underreported adverse event of immune checkpoint inhibitor therapy, an established cancer treatment option. Differentiation among other cutaneous manifestations of adverse medication reactions—such as Stevens–Johnson syndrome, erythema multiforme, and drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome—is crucial for guiding management.
format Online
Article
Text
id pubmed-10067804
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100678042023-04-04 A rare cutaneous manifestation of immune checkpoint inhibitor therapy Cherneskie, John Tuan, Alyssa Corey, Zachary Polimera, Hyma Clin Case Rep Case Images Leukocytoclastic vasculitis can be an uncommon and/or underreported adverse event of immune checkpoint inhibitor therapy, an established cancer treatment option. Differentiation among other cutaneous manifestations of adverse medication reactions—such as Stevens–Johnson syndrome, erythema multiforme, and drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome—is crucial for guiding management. John Wiley and Sons Inc. 2023-04-02 /pmc/articles/PMC10067804/ /pubmed/37020667 http://dx.doi.org/10.1002/ccr3.7151 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Images
Cherneskie, John
Tuan, Alyssa
Corey, Zachary
Polimera, Hyma
A rare cutaneous manifestation of immune checkpoint inhibitor therapy
title A rare cutaneous manifestation of immune checkpoint inhibitor therapy
title_full A rare cutaneous manifestation of immune checkpoint inhibitor therapy
title_fullStr A rare cutaneous manifestation of immune checkpoint inhibitor therapy
title_full_unstemmed A rare cutaneous manifestation of immune checkpoint inhibitor therapy
title_short A rare cutaneous manifestation of immune checkpoint inhibitor therapy
title_sort rare cutaneous manifestation of immune checkpoint inhibitor therapy
topic Case Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067804/
https://www.ncbi.nlm.nih.gov/pubmed/37020667
http://dx.doi.org/10.1002/ccr3.7151
work_keys_str_mv AT cherneskiejohn ararecutaneousmanifestationofimmunecheckpointinhibitortherapy
AT tuanalyssa ararecutaneousmanifestationofimmunecheckpointinhibitortherapy
AT coreyzachary ararecutaneousmanifestationofimmunecheckpointinhibitortherapy
AT polimerahyma ararecutaneousmanifestationofimmunecheckpointinhibitortherapy
AT cherneskiejohn rarecutaneousmanifestationofimmunecheckpointinhibitortherapy
AT tuanalyssa rarecutaneousmanifestationofimmunecheckpointinhibitortherapy
AT coreyzachary rarecutaneousmanifestationofimmunecheckpointinhibitortherapy
AT polimerahyma rarecutaneousmanifestationofimmunecheckpointinhibitortherapy

Ejemplares similares